Early stage HER2-positive breast carcinoma

Clinical trials for Early stage HER2-positive breast carcinoma explained in plain language.

Never miss a new study

Get alerted when new Early stage HER2-positive breast carcinoma trials appear

Sign up with your email to follow new studies for Early stage HER2-positive breast carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Could some breast cancer patients skip extra treatment? new trial investigates

Disease control Recruiting now

This phase II trial is testing whether patients with early HER2-positive or triple-negative breast cancer who had a complete response to pre-surgery treatment and have no cancer DNA in their blood can safely receive less therapy after surgery. The goal is to reduce side effects w…

Matched conditions: EARLY STAGE HER2-POSITIVE BREAST CARCINOMA

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

Early stage HER2-positive breast carcinoma

Get alerted when new Early stage HER2-positive breast carcinoma trials appear

Could some breast cancer patients skip extra treatment? new trial investigates